CClinicalTrials.gg
Active, not recruitingNCT07192302Updated Jan 16, 2026

Partial Rotator Cuff Injury Combined With Stiff Shoulder

A Phase 1 interventional study of Arthroscopy and Drugs administration in Rotator Cuff Tears of the Shoulder, Shoulder Adhesive Capsulitis and Shoulder Arthroscopy, sponsored by Hebei Medical University Third Hospital. Active, not recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-01-16.

Sponsored by Hebei Medical University Third Hospital · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

A Randomized Controlled Trial Comparing Early Surgical Intervention Versus a Structured Rehabilitation Program with Delayed Surgery if Needed for Partial-Thickness Rotator Cuff Tears with Concomitant Shoulder Stiffness: The SPIRIT Trial (Surgery for Partial Tears with Immobility Randomized Intervention Trial)

Read the detailed description

Objective: To compare the clinical and functional outcomes of early surgical intervention (arthroscopic debridement/repair and capsular release) versus an initial structured, supervised rehabilitation program with delayed surgery only for non-responders, in patients with PTRCT and shoulder stiffness.

Methods: This will be a single-center, prospective, randomized, controlled, parallel-group trial. patients will be randomized (1:1) to either:

Group A (Early Surgery): Arthroscopic surgery within 6 weeks of randomization.

Group B (Rehabilitation-First): A 6-month structured physical therapy program. Patients who do not achieve a pre-defined successful outcome at 6 months will then undergo delayed surgery.

Primary outcome will be the change in the American Shoulder and Elbow Surgeons (ASES) Standardized Shoulder Assessment Score from baseline to 12 months. Secondary outcomes include pain (VAS), range of motion (ROM), Constant-Murley Score, Single Assessment Numeric Evaluation (SANE), and rates of conversion to surgery. Outcomes will be assessed at baseline 6 months and 6 months after surgery.

Expected Outcomes: The investigators hypothesize that the early surgery group will demonstrate faster initial improvement in pain and function. However, the investigators anticipate that by 6 months, a significant proportion of the rehabilitation-first group will avoid surgery altogether and achieve non-inferior, if not equivalent, outcomes compared to the early surgery group.

02

Conditions studied

  • Rotator Cuff Tears of the Shoulder
  • Shoulder Adhesive Capsulitis
  • Shoulder Arthroscopy

Browse trials for

03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age 18-80 years.
  2. Symptomatic shoulder pain for >2 weeks.
  3. MRI-confirmed partial-thickness rotator cuff tear (>50% tendon thickness or >5mm in length).
  4. Concomitant shoulder stiffness, defined as passive range of motion loss of ≥25% in at least two planes (forward flexion, abduction, external rotation, or internal rotation) compared to the contralateral side.
  5. Failure of a brief (≥2 weeks) trial of conservative care (e.g., oral NSAIDs).

Exclusion criteria

Exclusion Criteria:

  1. Age\< 18 or >80 years.
  2. Full-thickness rotator cuff tear.
  3. Previous surgery on the affected shoulder.
  4. Glenohumeral osteoarthritis (Grade ≥2 Samilson-Prieto).
  5. Cervical radiculopathy as a primary cause of symptoms.
  6. Systemic inflammatory arthritis.
  7. Neurologic disorder affecting the shoulder.
  8. Contraindications to surgery or general anesthesia.
  9. Inability to comply with the rehabilitation protocol.
04

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Group A (Early Surgery)

    : Arthroscopic surgery within 6 weeks

    Procedure: Arthroscopy

  • Sham comparator
    Group B (Rehabilitation-First)

    6-month structured physical therapy program. Patients who do not achieve a pre-defined successful outcome at 6 months will then undergo delayed surgery.

    Drug: Drugs administration

Interventions

  • ProcedureArthroscopy

    Early Surgical Intervention in Patients with Partial Rotator Cuff Tears and Concomitant Shoulder Stiffness.

  • DrugDrugs administration

    Oral Medication for Conservative Management of Partial Rotator Cuff Tears with Concomitant Shoulder Stiffness.

05

What researchers measure

Primary outcomes

  1. Shoulder Pain and Disability Index (SPADI)

    Shoulder Pain and Disability Index (SPADI) from 0-100. The lower the number, the better the functional outcomes of the patients.

    Time frame: 6 month before surgery and 6 months after surgery

06

Study locations

1 site
  • Jialiang Guo
    Shijiazhuang, Hebei 050000, China
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07192302
Lead sponsor
Hebei Medical University Third Hospital
Responsible party
Sponsor
First posted
Sep 25, 2025
Start date
Jun 1, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jan 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion